Coronavirus Infections clinical trials

The registry lists 1,112 studies for Coronavirus Infections across more than 10 countries. 52 are recruiting or about to start. 280 of them are mainly about Coronavirus Infections (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 3 narrower conditions too, such as COVID-19: 8,802 studies, 638 open.

ClinicalTrials.gov finds 8,576 studies for Coronavirus Infections. How that becomes 1,112 here

This page counts the studies the registry files under Coronavirus Infections, and those it files under no condition that list Coronavirus Infectionsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

8,576Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
−7,301Filed under a narrower condition, counted on its own pageCOVID-19 6,788 · Post-Acute COVID-19 Syndrome 394 · Severe Acute Respiratory Syndrome 64
−4List Coronavirus Infections as a condition, but the registry did not file them under itMost often written as “Middle East Respiratory Syndrome Coronavirus (MERS-CoV)” (1), “Middle East Respiratory Syndrome Coronavirus” (1), and “Novel Coronavirus Infection” (1). The registry filed 4 of them under no condition at all.
−159Match it another way7 name it in the title and 152 by a synonym or other text the search reads.
1,112The count on this page

Get an email when these change. Save the Coronavirus Infections studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 644
Status unknown: 192
Terminated: 123
Withdrawn: 59
Recruiting: 40
Active, not recruiting: 26

Phase

Phase 2: 274
Phase 3: 171
Phase 1: 124
Phase 4: 44
Early Phase 1: 9

Where

United States: 401
France: 89
Brazil: 70
Spain: 69
United Kingdom: 69
Canada: 57

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (33) · ModernaTX, Inc. (30) · BioNTech SE (14) · University of Oxford (11) · Columbia University (10) · Assistance Publique - Hôpitaux de Paris (10) · University of Milano Bicocca (8) · University of Minnesota (8)

What is being tested here

Drugs under test in Coronavirus Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
BNT162 Vaccine	2	8	13
2019-nCoV Vaccine mRNA-1273	2	5	11
MRNA-1283	2	0	5
Ibuzatrelvir	2	2	2
Nitazoxanide	1	2	7
Remdesivir	1	4	6
Baricitinib	1	3	5
CHO Cells	1	0	5
Ebselen	1	0	2
Oplunofusp	1	2	2

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 1 open · JAK inhibitors 1 open · Corticosteroids 10 · Angiotensin receptor blockers (ARBs) 7 · Factor Xa inhibitors 6

Coming up

11phase 3 studies under way

23studies finish main data collection within a year5 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Nov 2026Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID · Phase 3 · Wes Ely
Apr 2027A Study of COVID-19 Vaccine(s) in Children and Adults · Phase 3 · BioNTech SE
Sep 2027A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
Oct 2027A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease · Phase 3 · Pfizer
Nov 2027Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen · Phase 3 · AstraZeneca
Nov 2026Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) · Duke University
Nov 2026Long Term Outcomes of Patients With COVID-19 · University of Chicago
Nov 2026A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · National Institute of Allergy and Infectious Diseases (NIAID)
Dec 2026Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic · University of California, San Francisco
Dec 2026A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations · ModernaTX, Inc.

Who these studies take

Of the 40 Coronavirus Infections studies recruiting now, 24 (60%) set no upper age limit and 9 (23%) stop at 75 or younger. 13 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 20 (50%) take healthy volunteers.

Recruiting studies that take each age, of 40
Age	Women	Men
10	11 (28%)	11 (28%)
18	37 (93%)	37 (93%)
30	36 (90%)	36 (90%)
40	37 (93%)	37 (93%)
50	37 (93%)	37 (93%)
65	33 (83%)	33 (83%)
75	31 (78%)	31 (78%)
85	31 (78%)	31 (78%)

Across all 1,112 studies, recruiting or not: 20% stop at 75 or younger and 14% at 65; 18% take children; 2% are for women only and <1% for men only; 32% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Coronavirus Infections studies take

Of 107 phase 2 interventional studies under Coronavirus Infections, half reached primary completion within 9 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Phase 1	10 mo3–18 · 61 studies	7 mo2–15 · 35 studies	15 mo8–19 · 26 studies
Phase 1/2	13 mo7–25 · 38 studies	—	—
Phase 2	9 mo5–15 · 107 studies	8 mo5–14 · 38 studies	9 mo4–15 · 69 studies
Phase 2/3	9 mo4–27 · 32 studies	—	—
Phase 3	11 mo5–20 · 91 studies	11 mo4–25 · 35 studies	11 mo5–16 · 56 studies
Phase 4	8 mo3–15 · 32 studies	—	7 mo2–14 · 26 studies
Interventional, no phase	8 mo3–14 · 133 studies	—	8 mo3–16 · 113 studies
Observational	14 mo5–26 · 245 studies	—	15 mo5–28 · 228 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 1,112. Browse all 1,112 → or search them.